Characterization of malignant colon tumors with31p nuclear magnetic resonance phospholipid and phosphatic metabolite profiles
Authors:
- Pamela M. DiamantisPDPamela M. Diamantis
- Toni HaidaTHToni Haida
Open Access
- 15 November 1995
- Vol. 76 (10) , 1715-1723
Abstract
Background. To further characterize selected pathologic features on a biochemical level, the authors analyzed the nuclear magnetic resonance metabolite and phospholipid spectra of 30 malignant colon tumors using 31P magnetic resonance spectroscopy. Methods. Eleven individual generic phospholipids were identified in the spectra of 17 phospholipid extracts, and 31 individual phosphatic metabolites were identified in the spectra of 13 perchloric acid extracts. The metabolites and lipids were quantified for statistical intergroup comparisons based on tumor stage, lymph node status, differentiation, mucin production, blood vessel invasion (BVI), and lymphatic vessel invasion (LVI). Results. Significant elevations in the relative concentration of α-glycerol phosphate were noted when comparing AJCC tumor classification (T3 vs. T2, 0.92 ± 0.14 vs. 0.46 ± 0.11, P < 0.009), tumor differentiation (moderately vs. well differentiated, 0.92 ± 0.14 vs. 0.46 ± 0.11, P < 0.009), and BVI (presence vs. absence, 1.03 ± 0.04 vs. 0.68 ± 0.10, P < 0.028) by elastic tissue stain. Among the tissue phospholipids analyzed, the relative concentration of a choline phospholipid was significantly different when comparing moderately and poorly differentiated tumors (6.26 ± 0.56 vs. 3.29 ± 0.30, P < 0.001), T2 and T3 tumors (3.90 ± 0.45 vs. 6.31 ± 0.56, P < 0.009), and mucin-positive vs. mucin-negative tumors (4.46 ± 0.56 vs. 6.83 ± 0.76, P < 0.028). Differences in lymph node status of the cases analyzed in this study (lymph node positive vs. lymph node negative) were noted for tumors with elevated levels of sphingomyelin (8.13 ± 0.40 vs. 6.88 ± 0.16, P < 0.02), diminished levels of phosphatidylinositol (5.25 ± 0.27 vs. 6.38 ± 0.34, P < 0.02), elevated levels of beta-glycerol phosphate (5.30 ± 0.70 vs. 1.20 ± 0.06, P < 0.05), and elevated levels of glycerol 3-phosphoserine (0.48 ± 0.01 vs. 0.23 ± 0.02, P< 0.002). Conclusions. The characteristic differences in the phospholipid and intermediate phosphate metabolite profiles identified through magnetic resonance spectroscopic and histopathologic analysis may provide important information regarding the nature of tumor and cell membrane metabolism. Differences in these profiles may identify markers useful for biologic behavior, provide prognostic information, and characterize the impact of the pathologic features of colon cancer. Cancer 1995; 76:1715–23.Keywords
This publication has 26 references indexed in Scilit:
- Analysis of magnetic resonance spectra by mole percent: Comparison to absolute unitsNeurobiology of Aging, 1994
- Algal phospholipids by 31P NMR: Comparing isopropanol pretreatment with simple chloroform/methanol extractionInternational Journal of Biochemistry, 1993
- Phosphodiesters in saponified extracts of human breast and colon tumors using31P magnetic resonance spectroscopyMagnetic Resonance in Medicine, 1992
- Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopyInternational Journal of Colorectal Disease, 1991
- Potentially curative surgery of colon cancer: the influence of blood vessel invasion.Journal of Clinical Oncology, 1988
- Potentially curative surgery of colon cancer: patterns of failure and survival.Journal of Clinical Oncology, 1988
- Prognostic indicators of colon tumors. The gastrointestinal tumor study group experienceCancer, 1986
- A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancerBritish Journal of Surgery, 1985
- Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancerBritish Journal of Cancer, 1983
- Simplified wet ash procedure for total phosphorus analysis of organophosphonates in biological samplesAnalytical Chemistry, 1971